A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Inhibrx Biosciences, Inc
Sichuan Baili Pharmaceutical Co., Ltd.
Nurix Therapeutics, Inc.
AbbVie